Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Valvular Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 650 articles:
HTML format



Single Articles


    September 2021
  1. BRIZIDO C, Madeira M, Brito J, Madeira S, et al
    Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29948.
    PubMed     Abstract available


  2. MEDRANDA GA, Rogers T, Ali SW, Zhang C, et al
    Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29943.
    PubMed     Abstract available


  3. TANG GHL, Dangas GD
    Coronary access after valve-in-valve transcatheter aortic valve replacement: Time for a prospective study?
    Catheter Cardiovasc Interv. 2021;98:605-606.
    PubMed    


  4. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    PubMed    


    August 2021
  5. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  6. FERREIRA DE SALES I, Lodi-Junqueira L, Rafael Sant'Anna Athayde G, Eugenia Alcici M, et al
    Pulmonary artery pressure response to percutaneous mitral valvuloplasty: Associated factors and clinical implications.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29926.
    PubMed     Abstract available


  7. AMGAI B, Patel N, Chakraborty S, Bandyopadhyay D, et al
    30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29918.
    PubMed     Abstract available


  8. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    PubMed     Abstract available


  9. CHOI CH, Cao K, Malaver D, Kincaid EH, et al
    Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29921.
    PubMed     Abstract available


  10. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    PubMed     Abstract available


  11. FUKUTOMI M, Hokken T, Wong I, Bieliauskas G, et al
    Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29914.
    PubMed     Abstract available


  12. BRIGUORI C, Scarpelli M
    The "locking and dragging" technique a facilitated crossover balloon occlusion technique for complex iliofemoral anatomy in transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29915.
    PubMed     Abstract available


  13. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    PubMed     Abstract available


  14. NONA P, Mahmood S, Lemor A, Qintar M, et al
    Incidence of acquired ventricular septal defect after transcatheter aortic valve replacement: A large single center experience.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29897.
    PubMed     Abstract available


  15. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    PubMed     Abstract available


  16. TARANTINI G, Cardaioli F
    Transcatheter aortic valve replacement and chronic kidney disease: Close friends or sworn enemies?
    Catheter Cardiovasc Interv. 2021;98:328-329.
    PubMed    


  17. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    PubMed    


    July 2021
  18. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    PubMed     Abstract available


  19. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    PubMed     Abstract available


  20. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    PubMed     Abstract available


  21. GOITIA J, Phan DQ, Lee MS, Moore N, et al
    The role of neighborhood disadvantage in predicting mortality in patients after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29872.
    PubMed     Abstract available


  22. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    PubMed     Abstract available


  23. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 8. doi: 10.1002/ccd.29860.
    PubMed     Abstract available


  24. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  25. POSTALIAN A, Krajcer Z
    Transcatheter aortic valve replacement has not helped bridge the racial disparity gap.
    Catheter Cardiovasc Interv. 2021;98:157-158.
    PubMed    


  26. ELGENDY IY, Jneid H
    Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleterious.
    Catheter Cardiovasc Interv. 2021;98:195-196.
    PubMed    


    June 2021
  27. ISOGAI T, Saad AM, Michihata N, Ahuja KR, et al
    Association of hospital procedural volume with incidence and outcomes of surgical bailout in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 29. doi: 10.1002/ccd.29847.
    PubMed     Abstract available


  28. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    PubMed     Abstract available


  29. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study.
    Catheter Cardiovasc Interv. 2021 Jun 19. doi: 10.1002/ccd.29842.
    PubMed     Abstract available


  30. AL-KASSOU B, Shamekhi J, Weber M, Germeroth J, et al
    Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 18. doi: 10.1002/ccd.29821.
    PubMed     Abstract available


  31. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    PubMed     Abstract available


  32. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    PubMed     Abstract available


  33. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    PubMed     Abstract available


  34. ENG MH, Kargoli F, Wang DD, Frisoli TM, et al
    Short- and mid-term outcomes in percutaneous mitral valve replacement using balloon expandable valves.
    Catheter Cardiovasc Interv. 2021 Jun 9. doi: 10.1002/ccd.29783.
    PubMed     Abstract available


  35. MAIER O, Piayda K, Afzal S, Polzin A, et al
    Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29805.
    PubMed     Abstract available


  36. SCHOECHLIN S, Schulz U, Ruile P, Hein M, et al
    Impact of high-sensitivity cardiac troponin T on survival and rehospitalization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29781.
    PubMed     Abstract available


  37. NICOLAS J, Mehran R
    Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved.
    Catheter Cardiovasc Interv. 2021;97:1470-1471.
    PubMed    


  38. TARANTINI G, Nai Fovino L
    Treatment of degenerated surgical aortic valve: The importance of having a "lifetime strategy" in younger patients with severe aortic disease.
    Catheter Cardiovasc Interv. 2021;97:1489-1491.
    PubMed    


  39. REILLY JP, Parikh PB
    Transcarotid transcatheter aortic valve replacement: The best alternative?
    Catheter Cardiovasc Interv. 2021;97:1460-1461.
    PubMed    


    May 2021
  40. EL-SABAWI B, Guerrero ME, Eleid MF, Nkomo VT, et al
    Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29779.
    PubMed     Abstract available


  41. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  42. ROMEO FJ, Chiabrando JG, Seropian IM, Raleigh JV, et al
    Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 27. doi: 10.1002/ccd.29799.
    PubMed     Abstract available


  43. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    PubMed     Abstract available


  44. MCGRATH DP, Kawabori M, Wessler B, Chen FY, et al
    A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 12. doi: 10.1002/ccd.29768.
    PubMed     Abstract available


  45. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    PubMed     Abstract available


  46. ARANZULLA TC, Musumeci G
    Clipping mitral valve or atrial fibrillation? Two is better than one!
    Catheter Cardiovasc Interv. 2021;97:1257-1258.
    PubMed    


  47. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    PubMed    


    April 2021
  48. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    PubMed     Abstract available


  49. HERRMANN HC, Laskey WK
    Pressure loss recovery in aortic valve stenosis: Contemporary relevance.
    Catheter Cardiovasc Interv. 2021 Apr 22. doi: 10.1002/ccd.29729.
    PubMed     Abstract available


  50. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    PubMed     Abstract available


  51. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    PubMed     Abstract available


  52. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    PubMed     Abstract available


  53. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    PubMed     Abstract available


  54. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    PubMed     Abstract available


  55. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  56. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  57. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    PubMed     Abstract available


  58. MUSUMECI G, Colopi M
    Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care.
    Catheter Cardiovasc Interv. 2021;97:925-926.
    PubMed    


  59. MAHTTA D, Jneid H
    Paravalvular leak after TAVR: remarkable improvement but not the time to shift focus.
    Catheter Cardiovasc Interv. 2021;97:903-904.
    PubMed    


  60. LANDES U, Kornowski R
    Same day discharge: How much less is more for TAVR patients?
    Catheter Cardiovasc Interv. 2021;97:948-949.
    PubMed    


    March 2021
  61. WEICH H, van Veyeren LM
    A new over-the-wire percutaneous mitral balloon valvuloplasty technique.
    Catheter Cardiovasc Interv. 2021 Mar 31. doi: 10.1002/ccd.29664.
    PubMed     Abstract available


  62. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    PubMed     Abstract available


  63. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    PubMed     Abstract available


  64. GRANOT Y, Merdler I, Finkelstein A, Arbel Y, et al
    Prognostic implication of right ventricular dysfunction and tricuspid regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Mar 7. doi: 10.1002/ccd.29639.
    PubMed     Abstract available


  65. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    PubMed     Abstract available


  66. AKHTAR YN, Walker WA, Shakur U, Smith G, et al
    Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users.
    Catheter Cardiovasc Interv. 2021 Mar 1. doi: 10.1002/ccd.29584.
    PubMed     Abstract available


  67. POSTALIAN A, Krajcer Z
    The best option to treat transplant recipients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2021;97:699-700.
    PubMed    


  68. KONERU S, Jneid H
    Rescue valve-in-valve TAVI: Buy one get one free!
    Catheter Cardiovasc Interv. 2021;97:712-713.
    PubMed    


  69. ENG MH, Fang HK
    Transcarotid: A sign from above?
    Catheter Cardiovasc Interv. 2021;97:734-735.
    PubMed    


    February 2021
  70. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  71. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    PubMed     Abstract available


  72. SHARMA RK, Tuttle MK, Poulin MF, Laham RJ, et al
    CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29544.
    PubMed     Abstract available


  73. CAUGHRON H, Parikh D, Allison Z, Deuse T, et al
    Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29559.
    PubMed     Abstract available


  74. KHOKHAR AA, Laricchia A, Ponticelli F, Kim WK, et al
    Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.
    Catheter Cardiovasc Interv. 2021 Feb 14. doi: 10.1002/ccd.29503.
    PubMed     Abstract available


  75. THANDRA A, Abusnina W, Jhand A, Shaikh K, et al
    Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta-analysis comparing midterm outcomes.
    Catheter Cardiovasc Interv. 2021 Feb 13. doi: 10.1002/ccd.29541.
    PubMed     Abstract available


  76. ADLAM D, Chan N, Baron J, Kovac J, et al
    Aortic stenosis in the time of COVID-19: Development and outcomes of a rapid turnaround TAVI service.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29550.
    PubMed     Abstract available


  77. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    PubMed     Abstract available


  78. KIR D, Shapero K, Chatterjee S, Grimshaw A, et al
    Effect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29502.
    PubMed     Abstract available


  79. BANGALORE S, Alviar CL, Vlahakis S, Keller N, et al
    Tricuspid valve vegetation debulking using the AngioVac system.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29519.
    PubMed     Abstract available


  80. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    PubMed     Abstract available


  81. YONG MS, Camuglia AC, Cox SV, Cole CM, et al
    Plaster pipes and crystalized graphite: Open transventricular transcatheter aortic valve replacement for failed mechanical aortic valve prostheses in the porcelain aorta.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29465.
    PubMed     Abstract available


  82. AL-HIJJI MA, ElHajj S, El Sabbagh A, Alkhouli MA, et al
    Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29515.
    PubMed     Abstract available


  83. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  84. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  85. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    PubMed     Abstract available


  86. ERINNE I, Sethi A, Johannesen J, Kassotis J, et al
    Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap?
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29487.
    PubMed     Abstract available


  87. POSTALIAN A, Krajcer Z
    How often is urgent surgery required to address transcatheter mitral valve repair complications?
    Catheter Cardiovasc Interv. 2021;97:342-343.
    PubMed    


  88. ENG MH, Verma DR
    Mitral valve-in-ring: Simply complicated.
    Catheter Cardiovasc Interv. 2021;97:359-360.
    PubMed    


  89. MUSUMECI G, Annibali G
    Access site vascular complications in TAVR: Is this the right time?
    Catheter Cardiovasc Interv. 2021;97:333-334.
    PubMed    


    January 2021
  90. SIMARD T, Alqahtani F, Hibbert B, Mamas MA, et al
    Sex-specific in-hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves.
    Catheter Cardiovasc Interv. 2021 Jan 31. doi: 10.1002/ccd.29499.
    PubMed     Abstract available


  91. SAMMOUR Y, Kerrigan J, Banerjee K, Gajulapalli RD, et al
    Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience.
    Catheter Cardiovasc Interv. 2021 Jan 29. doi: 10.1002/ccd.29496.
    PubMed     Abstract available


  92. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    PubMed     Abstract available


  93. CARRETERO BELLON JM, Morr IC, Merchan EF, Prada FH, et al
    Expanding percutaneous treatment of mitral valve diseases: Transcatheter closure of mitral valve leaflet perforation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29467.
    PubMed     Abstract available


  94. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    PubMed     Abstract available


  95. ITO N, Zen K, Kuwabara K, Matoba S, et al
    Recapture failure in transcatheter aortic valve replacement with CoreValve Evolut R.
    Catheter Cardiovasc Interv. 2021 Jan 22. doi: 10.1002/ccd.29580.
    PubMed     Abstract available


  96. SCHOTT JP, Dixon SR, Goldstein JA
    Disparate impact of severe aortic and mitral regurgitation on left ventricular dilation.
    Catheter Cardiovasc Interv. 2021 Jan 20. doi: 10.1002/ccd.29455.
    PubMed     Abstract available


  97. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    PubMed     Abstract available


  98. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    PubMed     Abstract available


  99. ROHM CL, Farhat S, Al-Hijji M, Goel K, et al
    Endovascular snare technique to facilitate delivery of self-expanding valve during transcatheter aortic valve-in-valve replacement in angulated aortas: A case series.
    Catheter Cardiovasc Interv. 2021 Jan 11. doi: 10.1002/ccd.29459.
    PubMed     Abstract available


  100. ELBADAWI A, Ugwu J, Elgendy IY, Megaly M, et al
    Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients.
    Catheter Cardiovasc Interv. 2021 Jan 5. doi: 10.1002/ccd.29426.
    PubMed     Abstract available


  101. MARMAGKIOLIS K, Cilingiroglu M
    TAVR in cancer; healing the sickest of the sick.
    Catheter Cardiovasc Interv. 2021;97:165-166.
    PubMed    


    December 2020
  102. PERDONCIN E, Greenbaum AB, Grubb KJ, Babaliaros VC, et al
    Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
    Catheter Cardiovasc Interv. 2020 Dec 31. doi: 10.1002/ccd.29453.
    PubMed     Abstract available


  103. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    PubMed     Abstract available


  104. PHAN DQ, Lee MS, Aharonian V, Mansukhani P, et al
    Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29429.
    PubMed     Abstract available


  105. LECLERCQ F, Choteau R, Cayla G, Chamard C, et al
    Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29438.
    PubMed     Abstract available


  106. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    PubMed     Abstract available


  107. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    PubMed     Abstract available


  108. KRAJCER Z, Costello B
    Effect of concomitant aortic regurgitation on early hypoattenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020;96:1498-1499.
    PubMed     Abstract available


    November 2020
  109. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  110. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    PubMed     Abstract available


  111. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    PubMed     Abstract available


  112. RZUCIDLO J, Jaspan V, Paone D, Jilaihawi H, et al
    Long-term outcomes after transcatheter aortic valve replacement with minimal contrast in chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29378.
    PubMed     Abstract available


  113. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    PubMed     Abstract available


  114. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    PubMed     Abstract available


  115. ARORA S, Lahewala S, Zuzek Z, Thakkar S, et al
    Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience.
    Catheter Cardiovasc Interv. 2020 Nov 9. doi: 10.1002/ccd.29379.
    PubMed     Abstract available


  116. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    PubMed     Abstract available


  117. CHIARITO M, Mehran R
    Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough?
    Catheter Cardiovasc Interv. 2020;96:1110-1112.
    PubMed    


  118. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  119. TARANTINI G, Masiero G
    Combined edge-to-edge tricuspid and mitral valve repair: Promising but still a long and bumpy road.
    Catheter Cardiovasc Interv. 2020;96:1331-1332.
    PubMed    


  120. POSTALIAN A, Krajcer Z
    Preventing tricuspid valve injury during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2020;96:1294-1295.
    PubMed     Abstract available


    October 2020
  121. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    PubMed     Abstract available


  122. SIMONETTO F, Purita PAM, Malerba M, Barbierato M, et al
    Surgical redo versus transseptal or transapical transcatheter mitral valve-in-valve implantation for failed mitral valve bioprosthesis.
    Catheter Cardiovasc Interv. 2020 Oct 13. doi: 10.1002/ccd.29324.
    PubMed     Abstract available


  123. CHAWLA KK, Huang X, Hadro N, Islam AM, et al
    A novel technique to manage transcatheter aortic valve embolization.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29279.
    PubMed     Abstract available


  124. SAMMOUR Y, Sato K, Kumar A, Gajulapalli RD, et al
    Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29309.
    PubMed     Abstract available


  125. NICOLAS J, Claessen BE, Cao D, Sartori S, et al
    Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29276.
    PubMed     Abstract available


  126. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    PubMed     Abstract available


  127. MISUMIDA N, Guerrero M, Pislaru SV, Alkhouli M, et al
    Hemodynamic response to transseptal transcatheter mitral valve replacement in patients with severe mitral stenosis due to severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29285.
    PubMed     Abstract available


  128. TARANTINI G, Nai Fovino L
    TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more.
    Catheter Cardiovasc Interv. 2020;96:956-957.
    PubMed    


  129. OOI YS, Gray WA
    One in one equals two.
    Catheter Cardiovasc Interv. 2020;96:987-988.
    PubMed    


  130. ARANZULLA TC, Musumeci G
    Remove the obstacle and get into the flow!
    Catheter Cardiovasc Interv. 2020;96:979-980.
    PubMed    


    September 2020
  131. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  132. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    PubMed     Abstract available


  133. MORITA Y, Endo A, Tanabe K
    Papillary muscle rupture after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
    PubMed     Abstract available


  134. MORIYAMA N, Lehtola H, Miyashita H, Piuhola J, et al
    Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29281.
    PubMed     Abstract available


  135. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    PubMed     Abstract available


  136. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    PubMed    


  137. ALSHAWABKEH L, Mahmud E, Reeves R
    Percutaneous mitral valve repair in adults with congenital heart disease: Report of the first case-series.
    Catheter Cardiovasc Interv. 2020 Sep 8. doi: 10.1002/ccd.29238.
    PubMed     Abstract available


  138. KOMATSU I, Tang GHL, Leipsic J, Webb JG, et al
    Distribution of C-arm projections in native and bioprosthetic aortic valves cusps: Implication for BASILICA procedures.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29224.
    PubMed     Abstract available


  139. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    PubMed     Abstract available


  140. TARANTINI G, Baumgartner H, Frank D, Husser O, et al
    Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3.
    Catheter Cardiovasc Interv. 2020 Sep 4. doi: 10.1002/ccd.29257.
    PubMed     Abstract available


  141. ANUWATWORN A, Bailey SR
    Predicting who benefits from mitral valve percutaneous repair: It's not just the valve.
    Catheter Cardiovasc Interv. 2020;96:698.
    PubMed    


  142. TARANTINI G, Masiero G
    Early readmission after mitral valve repair: God is in the details.
    Catheter Cardiovasc Interv. 2020;96:675-677.
    PubMed    


  143. ZAHR F, Cigaarroa JE
    Left atrial function, the cherrie on top in understanding clinical outcomes in functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020;96:685-686.
    PubMed    


  144. PATEL ND, Nageotte S, Ing FF, Armstrong AK, et al
    Procedural, pregnancy, and short-term outcomes after fetal aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2020;96:626-632.
    PubMed     Abstract available


  145. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  146. PULS M, Huenlich M, Boekstegers P, Lubos E, et al
    Implantation of one versus two MitraClips in the German TRAMI registry: Is more always better?
    Catheter Cardiovasc Interv. 2020;96:E360-E368.
    PubMed     Abstract available


  147. JOHNSON DT, Fournier S, Kirkeeide RL, De Bruyne B, et al
    Phasic pressure measurements for coronary and valvular interventions using fluid-filled catheters: Errors, automated correction, and clinical implications.
    Catheter Cardiovasc Interv. 2020;96:E268-E277.
    PubMed     Abstract available


  148. PAL N, Jones D, Rice G, Sinhal A, et al
    Case report describing late balloon dilatation as a treatment for paravalvular leak with intuity elite rapid deployment valve.
    Catheter Cardiovasc Interv. 2020;96:E292-E294.
    PubMed     Abstract available


  149. SATHANANTHAN J, Hensey M, Fraser R, Landes U, et al
    Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.
    Catheter Cardiovasc Interv. 2020;96:E332-E340.
    PubMed     Abstract available


    August 2020
  150. TONCHEV I, Heberman D, Peretz A, Medvedovsky AT, et al
    Acute kidney injury after MitraClip implantation in patients with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29250.
    PubMed     Abstract available


  151. SEKARAN N, Horne BD, Doty JR, Reid BB, et al
    Transcatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29232.
    PubMed     Abstract available


  152. PANOULAS VF, Chandrasekhar J, Busi G, Ruparelia N, et al
    Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29227.
    PubMed     Abstract available


  153. RUGGIERO R, Ponticelli F, Giannini F, Galvani M, et al
    Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29249.
    PubMed     Abstract available


  154. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    PubMed     Abstract available


  155. MAZZELLA AJ, Sanders M, Yang H, Li Q, et al
    Predicting need for pacemaker implantation early and late after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29239.
    PubMed     Abstract available


  156. SAWALHA K, Al-Akchar M, Ibrahim A, Buhnerkempe M, et al
    Impact of chronic kidney disease on in-hospital outcomes and readmission rate after edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Aug 15. doi: 10.1002/ccd.29188.
    PubMed     Abstract available


  157. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    PubMed     Abstract available


  158. DI CESARE A, Tonet E, Campo G, Tumscitz C, et al
    Snuffbox approach for balloon aortic valvuloplasty: A case series.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29196.
    PubMed     Abstract available


  159. MYAT A, Buckner L, Mouy F, Cockburn J, et al
    In-hospital stroke after transcatheter aortic valve implantation: A UK observational cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 11. doi: 10.1002/ccd.29157.
    PubMed     Abstract available


  160. KHAN MU, Khan MZ, Khan SU, Kaluski E, et al
    Transcatheter mitral valve repair in patients with chronic liver disease: Insights from the national inpatient sample.
    Catheter Cardiovasc Interv. 2020 Aug 8. doi: 10.1002/ccd.29173.
    PubMed     Abstract available


  161. ISOGAI T, Saad AM, Shekhar S, Ahuja KR, et al
    Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Aug 8. doi: 10.1002/ccd.29153.
    PubMed     Abstract available


  162. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    PubMed     Abstract available


  163. MAOZ-METZL D, McCarthy FH, Berson DG, Kunz GA, et al
    Transcatheter tricuspid valve replacement in dehisced flexible ring.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29162.
    PubMed     Abstract available


  164. TARANTINI G, Fabris T
    Minimalist transfemoral transcatheter aortic valve replacement: Make it as simple as possible, but not simpler.
    Catheter Cardiovasc Interv. 2020;96:471-472.
    PubMed     Abstract available


  165. OLIVEIRA FA, Lemos PA
    TAVR patients count on their thrombocytes: Platelets count is accountable for the outcomes!
    Catheter Cardiovasc Interv. 2020;96:422-423.
    PubMed     Abstract available


  166. MUSUMECI G, Albani S
    US-guided vascular access and left ventricular rapid pacing in TAVR: Two simple points that may improve patients' outcomes.
    Catheter Cardiovasc Interv. 2020;96:440-441.
    PubMed     Abstract available


  167. TAN W, Calfon Press M, Lluri G, Aboulhosn J, et al
    Percutaneous edge-to-edge repair for common atrioventricular valve regurgitation in a patient with heterotaxy syndrome, single ventricle physiology, and unbalanced atrioventricular septal defect.
    Catheter Cardiovasc Interv. 2020;96:384-388.
    PubMed     Abstract available


  168. LAUCK SB, Sathananthan J, Park J, Achtem L, et al
    Post-procedure protocol to facilitate next-day discharge: Results of the multidisciplinary, multimodality but minimalist TAVR study.
    Catheter Cardiovasc Interv. 2020;96:450-458.
    PubMed     Abstract available


    July 2020
  169. ADDIS DR, Law M, von Mering G, Ahmed M, et al
    Codeployment of a percutaneous edge-to-edge mitral valve repair device and a ventriculoseptal defect occluder device to address complex mitral regurgitation with leaflet perforation.
    Catheter Cardiovasc Interv. 2020 Jul 31. doi: 10.1002/ccd.29147.
    PubMed     Abstract available


  170. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    PubMed     Abstract available


  171. RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
    Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
    PubMed     Abstract available


  172. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    PubMed     Abstract available


  173. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  174. ADAMO M, Provini M, Fiorina C, Giannini C, et al
    Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.
    Catheter Cardiovasc Interv. 2020 Jul 9. doi: 10.1002/ccd.28927.
    PubMed     Abstract available


  175. KHAN MZ, Khan MU, Kalra A, Krupica T, et al
    Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
    Catheter Cardiovasc Interv. 2020 Jul 7. doi: 10.1002/ccd.29109.
    PubMed     Abstract available


  176. FRACCARO C, Campante Teles R, Tchetche D, Saia F, et al
    Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29112.
    PubMed     Abstract available


  177. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    PubMed     Abstract available


  178. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    PubMed     Abstract available


  179. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    PubMed     Abstract available


  180. PARIKH PB, Reilly JP
    Women with chronic kidney disease undergoing transcatheter aortic valve replacement: Caveat emptor.
    Catheter Cardiovasc Interv. 2020;96:208-209.
    PubMed     Abstract available


  181. TARANTINI G, Giacoppo D
    Transcatheter versus surgical aortic valve replacement in the digital era: Meta-analysis based on the reconstruction of time-to-event individual patient data.
    Catheter Cardiovasc Interv. 2020;96:167-168.
    PubMed     Abstract available


  182. KORNOWSKI R
    Appraisal of urgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;96:196-197.
    PubMed     Abstract available


  183. LARICCHIA A, Mangieri A, Colombo A, Giannini F, et al
    Perceval sutureless valve migration treated by valve-in-valve with a CoreValve Evolut Pro.
    Catheter Cardiovasc Interv. 2020;96:225-227.
    PubMed     Abstract available


  184. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  185. STRIPE BR, Singh GD, Smith T, Rogers JH, et al
    Retrieval of a MitraClip from the left atrium using a two-snare technique: Case report and review of the literature.
    Catheter Cardiovasc Interv. 2020;96:210-214.
    PubMed     Abstract available


    June 2020
  186. ROTTLANDER D, Ballof J, Godde M, Degen H, et al
    CT-Angiography to predict outcome after indirect mitral annuloplasty in patients with functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Jun 30. doi: 10.1002/ccd.29107.
    PubMed     Abstract available


  187. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    PubMed     Abstract available


  188. BODE MF, Ahmed AA, Baron SJ, Labib SB, et al
    The use of MitraClip to prevent posttranscatheter aortic valve replacement left ventricular "suicide".
    Catheter Cardiovasc Interv. 2020 Jun 26. doi: 10.1002/ccd.29100.
    PubMed     Abstract available


  189. KOVACH CP, Bell S, Kataruka A, Reisman M, et al
    Outcomes of urgent/emergent transcatheter mitral valve repair (MitraClip): A single center experience.
    Catheter Cardiovasc Interv. 2020 Jun 26. doi: 10.1002/ccd.29084.
    PubMed     Abstract available


  190. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    PubMed     Abstract available


  191. GEYER M, Keller K, Born S, Bachmann K, et al
    Predictors of short- and long-term outcomes of patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2020 Jun 12. doi: 10.1002/ccd.29068.
    PubMed     Abstract available


  192. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    PubMed     Abstract available


  193. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    PubMed     Abstract available


  194. GE Z, Pan W, Zhou D, Li W, et al
    Effect of a novel transcatheter edge-to-edge repair device on the three-dimensional geometry of mitral valve in degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.29002.
    PubMed     Abstract available


  195. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    PubMed     Abstract available


  196. TARANTINI G, Nai Fovino L
    Preexisting diastolic dysfunction in patients undergoing TAVR matters-But what about diastole the day after TAVR?
    Catheter Cardiovasc Interv. 2020;95:1338-1339.
    PubMed    


    May 2020
  197. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    PubMed     Abstract available


  198. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    PubMed     Abstract available


  199. OTERO D, Raza M, Kahlon T, Singh V, et al
    Transcatheter edge-to-edge mitral valve repair for annuloplasty ring dehiscence: The peri-ring approach.
    Catheter Cardiovasc Interv. 2020 May 21. doi: 10.1002/ccd.28952.
    PubMed     Abstract available


  200. SEPPELT PC, Mas-Peiro S, De Rosa R, Murray IM, et al
    Dynamics of cerebral oxygenation during rapid ventricular pacing and its impact on outcome in transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28975.
    PubMed     Abstract available


  201. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  202. XIONG TY, Liao YB, Li YJ, Chen F, et al
    Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28903.
    PubMed     Abstract available


  203. GORLA R, De Marco F, Garatti A, Bianchi G, et al
    Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28957.
    PubMed     Abstract available


  204. GREENBAUM AB, Khan JM, Rogers T, Babaliaros VC, et al
    First-in-human transcatheter pledget-assisted suture tricuspid annuloplasty for severe tricuspid insufficiency.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28955.
    PubMed     Abstract available


  205. OSMAN M, Khan MZ, Farjo PD, Khan MU, et al
    In-hospital outcomes of percutaneous mitral valve repair in patients with chronic obstructive pulmonary disease: insights from the national inpatient sample database.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28913.
    PubMed     Abstract available


  206. VEULEMANS V, Maier O, Bosbach G, Polzin A, et al
    Novel insights on outcome in horizontal aorta with self-expandable new-generation transcatheter aortic valve replacement devices.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28961.
    PubMed     Abstract available


  207. EL-SABAWI B, Guerrero ME, Eleid MF, Rihal CS, et al
    Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28944.
    PubMed     Abstract available


  208. LISKO J, Block PC
    The bicuspid aortic valve: Still a toothy problem.
    Catheter Cardiovasc Interv. 2020;95:1193-1194.
    PubMed     Abstract available


  209. SAIA F, Leone A
    Suprasternal access for transcatheter aortic valve implantation: All ways lead to Rome.
    Catheter Cardiovasc Interv. 2020;95:1184-1185.
    PubMed     Abstract available


  210. KIMMELSTIEL C, Rowin EJ
    Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit.
    Catheter Cardiovasc Interv. 2020;95:1219-1220.
    PubMed     Abstract available


  211. KASHTANOV MG, Rzhannikova AD, Chernyshev SD, Kardapoltsev LV, et al
    Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety.
    Catheter Cardiovasc Interv. 2020;95:1212-1218.
    PubMed     Abstract available


    April 2020
  212. MISUMIDA N, Anderson JH, Greason KL, Rihal CS, et al
    Antegrade transseptal transcatheter aortic valve replacement: Back to the future?
    Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28934.
    PubMed     Abstract available


  213. PIAYDA K, Wimmer AC, Sievert H, Hellhammer K, et al
    Contemporary use of balloon aortic valvuloplasty and evaluation of its success in different hemodynamic entities of severe aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Apr 27. doi: 10.1002/ccd.28950.
    PubMed     Abstract available


  214. NOGUCHI M, Tabata M, Obunai K, Shibayama K, et al
    Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28935.
    PubMed     Abstract available


  215. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  216. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


  217. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  218. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed     Abstract available


  219. PERRINO C, Esposito G
    Diastolic dysfunction in severe aortic stenosis: Old but still gold.
    Catheter Cardiovasc Interv. 2020;95:1032-1033.
    PubMed     Abstract available


  220. TARANTINI G, Fabris T
    Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.
    Catheter Cardiovasc Interv. 2020;95:991-992.
    PubMed     Abstract available


  221. ARANZULLA TC, Musumeci G
    The first love, you never forget. The last heart valve, you might remember better than the first.
    Catheter Cardiovasc Interv. 2020;95:1022-1023.
    PubMed     Abstract available


  222. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  223. JONES BM, Jobanputra Y, Krishnaswamy A, Mick S, et al
    Rapid ventricular pacing during transcatheter valve procedures using an internal device and programmer: A demonstration of feasibility.
    Catheter Cardiovasc Interv. 2020;95:1042-1048.
    PubMed     Abstract available


  224. EITAN A, Brinkmann C, Haselbach T, Witt J, et al
    Does valve in valve TAVR carry a higher risk for thromboembolic events compared to native valve TAVR?
    Catheter Cardiovasc Interv. 2020;95:1017-1021.
    PubMed     Abstract available


    March 2020
  225. SCHUELER R, Ozturk C, Laser JV, Wirth F, et al
    Right ventricular assessment in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28861.
    PubMed     Abstract available


  226. WEBER M, Jaenisch M, Spilker M, Pingel S, et al
    TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data.
    Catheter Cardiovasc Interv. 2020 Mar 19. doi: 10.1002/ccd.28852.
    PubMed     Abstract available


  227. MAHOWALD MK, Pislaru SV, Reeder GS, Padang R, et al
    Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28856.
    PubMed     Abstract available


  228. MIURA M, Vicentini L, Taramasso M, Maisano F, et al
    Tangled wire in a Dacron band during Cardioband transcatheter tricuspid annuloplasty-How to solve the problem.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28845.
    PubMed     Abstract available


  229. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Response to: Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28828.
    PubMed    


  230. IMAMURA T
    Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28829.
    PubMed    


  231. HENSEY M, Sathananthan J, Alkhodair A, Landes U, et al
    Single-center prospective study examining use of the Wattson temporary pacing guidewire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 9. doi: 10.1002/ccd.28832.
    PubMed     Abstract available


  232. KERN MJ, Seto AH, Ng AT, Yu JH, et al
    Effects of pericardial tamponade on the hemodynamics of aortic stenosis.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28826.
    PubMed     Abstract available


  233. KHAN MZ, Khan MU, Munir MB, Khan SU, et al
    Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28834.
    PubMed     Abstract available


  234. MURDOCH DJ, Sathananthan J, Hensey M, Alu MC, et al
    Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
    Catheter Cardiovasc Interv. 2020 Mar 2. doi: 10.1002/ccd.28811.
    PubMed     Abstract available


  235. TARANTINI G, Fabris T
    Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun.
    Catheter Cardiovasc Interv. 2020;95:817-818.
    PubMed     Abstract available


  236. ROWIN EJ, Kimmelstiel C
    Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire.
    Catheter Cardiovasc Interv. 2020;95:838-839.
    PubMed     Abstract available


  237. MUSUMECI G, Aranzulla TC
    Choose to fly higher rather than pacing around.
    Catheter Cardiovasc Interv. 2020;95:791-792.
    PubMed     Abstract available


  238. RUGE H, Erlebach M, Lieberknecht E, Lange R, et al
    Successful treatment of a paravalvular leak with balloon cracking and valve-in-valve TAVR.
    Catheter Cardiovasc Interv. 2020;95:859-862.
    PubMed     Abstract available


  239. GODART F, Baudelet JB, Soquet J, Onorato E, et al
    Antegrade transcatheter closure of a dehiscence of pulmonary bioprosthesis after pulmonary valve replacement with the Occlutech paravalvular leak device.
    Catheter Cardiovasc Interv. 2020;95:855-858.
    PubMed     Abstract available


  240. EL-SABAWI B, Nishimura RA, Guerrero ME, Rihal CS, et al
    Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    Catheter Cardiovasc Interv. 2020;95:830-837.
    PubMed     Abstract available


    February 2020
  241. NITA N, Scharnbeck D, Schneider LM, Seeger J, et al
    Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28779.
    PubMed     Abstract available


  242. POPOVIC B, Molho A, Varlot J, Fay R, et al
    Prognostic influence of acute decompensated heart failure in patients planned for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 26. doi: 10.1002/ccd.28813.
    PubMed     Abstract available


  243. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    PubMed     Abstract available


  244. VEULEMANS V, Polzin A, Piayda K, Zeus T, et al
    Early restenosis of a direct flow transcatheter aortic valve prosthesis.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28806.
    PubMed     Abstract available


  245. AHMED A, Alsidawi S, Bae R, Cavalcante J, et al
    Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28805.
    PubMed     Abstract available


  246. REIFF C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, et al
    3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28783.
    PubMed     Abstract available


  247. OZTURK C, Fasell T, Sinning JM, Werner N, et al
    Left atrial global function in chronic heart failure patients with functional mitral regurgitation after MitraClip.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28775.
    PubMed     Abstract available


  248. RAGHUNATHAN D, Garcia-Sayan E, Dhoble A, Smalling R, et al
    First-in-human report of MitraClip G4 implantation for severe degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28777.
    PubMed     Abstract available


  249. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  250. SERFAS JD, Turek J, Haney J, Krasuski RA, et al
    Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy.
    Catheter Cardiovasc Interv. 2020;95:E78-E83.
    PubMed     Abstract available


  251. YAP J, Chen S, Stripe BR, Smith TWR, et al
    Transseptal access for left heart structural interventions in the setting of prior atrial septal defect closure.
    Catheter Cardiovasc Interv. 2020;95:414-419.
    PubMed     Abstract available


  252. ALMALLA M, Kersten A, Altiok E, Marx N, et al
    Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:357-362.
    PubMed     Abstract available


  253. LLOYD JW, Rihal CS, Eleid MF
    Hemodynamics rounds: Hemodynamics of mitral valve interventions.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28755.
    PubMed     Abstract available


  254. ZUSMAN O, Barbash MI, Guetta V, Finkelstein A, et al
    Predicting the risk of late futile outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 5. doi: 10.1002/ccd.28761.
    PubMed     Abstract available


    January 2020
  255. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  256. BANDYOPADHYAY D, Sartori S, Baber U, Cao D, et al
    The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28752.
    PubMed     Abstract available


  257. SHATILA W, Krajcer Z
    Transcatheter aortic valve implantation: Do leaks matter?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28684.
    PubMed    


  258. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  259. TARANTINI G, Nai Fovino L
    Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28690.
    PubMed     Abstract available


  260. TABACHNICK D, Obokhae B, Harrington K, Brown DL, et al
    Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28695.
    PubMed     Abstract available


  261. ZHAO ZG, Feng Y, Liao YB, Li YJ, et al
    Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: A pilot study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28726.
    PubMed     Abstract available


  262. CAMAJ A, Claessen BE, Mehran R, Yudi MB, et al
    The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
    Catheter Cardiovasc Interv. 2020 Jan 13. doi: 10.1002/ccd.28717.
    PubMed     Abstract available


  263. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  264. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  265. CAPRETTI G, Urena M, Bouleti C, Himbert D, et al
    Transcatheter tricuspid valve-in-valve replacement: Making it simpler.
    Catheter Cardiovasc Interv. 2020;95:65-67.
    PubMed     Abstract available


    December 2019
  266. KAWAGUCHI T, Yamaji K, Ishizu K, Morinaga T, et al
    Effect of postdilatation following balloon expandable transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28676.
    PubMed     Abstract available


  267. LIMA FV, Kolte D, Rofeberg V, Molino J, et al
    Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28647.
    PubMed     Abstract available


  268. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  269. ELEID MF, Nishimura RA
    Aortic stenosis and the pulse contour: A true marker of severity?
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28674.
    PubMed     Abstract available


  270. WINKEL MG, Brugger N, Windecker S, Praz F, et al
    An unusual cause of recurrent mitral regurgitation after percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28651.
    PubMed     Abstract available


  271. DUNCAN A, Mirsadree S, Quarto C, Davies S, et al
    Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28658.
    PubMed     Abstract available


  272. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the Ame
    Catheter Cardiovasc Interv. 2019 Dec 16. doi: 10.1002/ccd.28671.
    PubMed     Abstract available


  273. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  274. ALI Z, Sharma P, Mengesha T, Dalmar A, et al
    Early clinical and procedural outcomes in large series of 34-mm self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28634.
    PubMed     Abstract available


  275. SCHYMIK G, Wendler O, Hengstenberg C, Ohlmann P, et al
    Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28621.
    PubMed     Abstract available


  276. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


    November 2019
  277. KOTRONIAS RA, Scarsini R, De Maria GL, Rajasundaram S, et al
    Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: Insights from the OxTAVI registry.
    Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28578.
    PubMed     Abstract available


  278. ASHLEY KE, Hillegass WB
    Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
    Catheter Cardiovasc Interv. 2019;94:818-819.
    PubMed     Abstract available


  279. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  280. FUGAR S, Behnamfar O, Okoh AK, Alabre AF, et al
    Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28519.
    PubMed     Abstract available


  281. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  282. DOWLING C, Firoozi S, Panoulas V, Dalby M, et al
    Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28512.
    PubMed     Abstract available


  283. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  284. PATEL K, Broyd C, Chehab O, Jerrum M, et al
    Transcatheter aortic valve implantation in acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28581.
    PubMed     Abstract available


  285. PAREKH DR, Krajcer Z
    Transapical transcatheter aortic valves. Down but definitely not out for the count.
    Catheter Cardiovasc Interv. 2019;94:745.
    PubMed    


    October 2019
  286. ELBADAWI A, Elgendy IY, Mentias A, Saad M, et al
    Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28563.
    PubMed     Abstract available


  287. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  288. GOEL S, Pasam RT, Wats K, Patel J, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28520.
    PubMed     Abstract available


  289. DE ROSA R, Murray MI, Schranz D, Mas-Peiro S, et al
    Short-term decrease of left atrial size predicts clinical outcome in patients with severe aortic stenosis undergoing TAVR.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28542.
    PubMed     Abstract available


  290. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  291. COSTA G, Buccheri S, Barbanti M, Picci A, et al
    Outcomes of three different new generation transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28524.
    PubMed     Abstract available


  292. KUNO T, Takagi H, Sugiyama T, Ando T, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28498.
    PubMed     Abstract available


  293. SINHA S, Khan A, Qureshi AM, Suh W, et al
    Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28505.
    PubMed     Abstract available


    September 2019
  294. DOWLING C, Kondapally Seshasai SR, Firoozi S, Brecker SJ, et al
    Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28504.
    PubMed     Abstract available


  295. SATHANANTHAN J, Hensey M, Sellers S, Barlow AM, et al
    Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: A bench study.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28503.
    PubMed     Abstract available


  296. HELMY T, Hui DS, Smart S, Lim MJ, et al
    Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2019 Sep 13. doi: 10.1002/ccd.28496.
    PubMed     Abstract available


  297. ATTINGER-TOLLER A, Bhindi R, Perlman GY, Murdoch D, et al
    Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28475.
    PubMed     Abstract available


  298. ZHONG C, Rokey R, Rolak S, Mesa J, et al
    Pregnancy and transcatheter aortic valve replacement in a severely stenotic Freestyle full aortic root stentless bioprosthesis.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28481.
    PubMed     Abstract available


  299. JOGU HR, Arora S, Strassle PD, Patel C, et al
    Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28479.
    PubMed     Abstract available


  300. WHITBECK MG
    Treatment of focal distal abdominal aortic stenosis with the GORE VIABAHN VBX balloon expandable covered stent.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28478.
    PubMed     Abstract available


  301. KORNOWSKI R
    Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.
    Catheter Cardiovasc Interv. 2019;94:446-447.
    PubMed     Abstract available


  302. CILINGIROGLU M, Margmakiolis K
    Predilatation for transcatheter aortic valve replacement: Still have a role?
    Catheter Cardiovasc Interv. 2019;94:479-480.
    PubMed     Abstract available


  303. ZAHR F, Cigarroa JE
    Replacing the mitral valve alone does not completely fix the heart!
    Catheter Cardiovasc Interv. 2019;94:467-468.
    PubMed     Abstract available


  304. MUSUMECI G, Cinconze S
    Relationship volume-outcome for transcatheter mitral-valve repair: When technique matters.
    Catheter Cardiovasc Interv. 2019;94:436-437.
    PubMed     Abstract available


    August 2019
  305. YOKOYAMA H, Mizuno S, Saito S
    Subacute hemolytic anemia after transcatheter edge-to-edge mitral valve repair: A case report.
    Catheter Cardiovasc Interv. 2019 Aug 30. doi: 10.1002/ccd.28482.
    PubMed     Abstract available


  306. PAGNOTTA PA, Sanz-Sanchez J, Regazzoli D, Ferrante G, et al
    One-stop-shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28466.
    PubMed     Abstract available


  307. RIZIK DG, Burke RF, Goldstein JA
    Urgent mechanical circulatory support and transcatheter mitral valve repair for refractory hemodynamic compromise.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28439.
    PubMed     Abstract available


  308. EUDAILEY KW, Olds A, Lewis CT, Nazif TN, et al
    Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28460.
    PubMed     Abstract available


  309. HUBRECHTS J, Cools B, Brown SC, Eyskens B, et al
    Percutaneous obliteration of the right ventricle to avoid coronary damage by sinusoids in patients with pulmonary atresia intact ventricular septum during staged single ventricle palliation.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28457.
    PubMed     Abstract available


  310. KANDA BS, Hoyt NE, Tavaf-Motamen H
    Paravalvular leak closure of acute mitral valve ring dehiscence during mitral valve-in-ring procedure.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28443.
    PubMed     Abstract available


  311. TARANTINI G, Nai Fovino L, D'Errigo P, Rosato S, et al
    Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28447.
    PubMed     Abstract available


  312. ANANTHA-NARAYANAN M, Malik U, Mbai M, Megaly M, et al
    Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 16. doi: 10.1002/ccd.28444.
    PubMed     Abstract available


  313. KAMPAKTSIS PN, Vavuranakis M, Choi DY, Sherifi I, et al
    Prognostic role of diastolic dysfunction in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28426.
    PubMed     Abstract available


  314. AL-ANI A, Hoffmann P, von Lueder T, Opdahl A, et al
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Aug 4. doi: 10.1002/ccd.28419.
    PubMed     Abstract available


    July 2019
  315. PINO JE, Shah V, Ramos Tuarez FJ, Kreidieh OI, et al
    The utility of pulmonary function testing in the preoperative risk stratification of patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28402.
    PubMed     Abstract available


  316. MOMENAH TS, Alsahari A, Ahmed E, Al Khalaf K, et al
    Transcatheter mitral valve-in-valve implantation in a pediatric patient.
    Catheter Cardiovasc Interv. 2019 Jul 11. doi: 10.1002/ccd.28390.
    PubMed     Abstract available


  317. MADUKAUWA-DAVID ID, Sadri V, Kamioka N, Midha PA, et al
    Transcatheter aortic valve deployment influences neo-sinus thrombosis risk: An in vitro flow study.
    Catheter Cardiovasc Interv. 2019 Jul 9. doi: 10.1002/ccd.28388.
    PubMed     Abstract available


    June 2019
  318. KERN MJ, Kim M, Yu J, Seto AH, et al
    Evaluation of the severity of mitral stenosis in patient with pulmonary hypertension: Role of exercise hemodynamics.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28381.
    PubMed     Abstract available


  319. NANJUDAPPA A, Bhagat A, Bates MC
    A rare cause of stroke after transcatheter aortic valve replacement: Retained foreign body.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28374.
    PubMed     Abstract available


  320. WERNER N, Puls M, Baldus S, Lubos E, et al
    Gender-related differences in patients undergoing transcatheter mitral valve interventions in clinical practice: 1-year results from the German TRAMI registry.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28372.
    PubMed     Abstract available


  321. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    PubMed     Abstract available


  322. STACHON P, Kaier K, Heidt T, Bothe W, et al
    Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361.
    PubMed     Abstract available


  323. BLOCK PC, Lisko JC
    Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?
    Catheter Cardiovasc Interv. 2019;93:1352-1353.
    PubMed     Abstract available


    May 2019
  324. AMAT-SANTOS IJ, Gutierrez H, Sathananthan J, Webb JG, et al
    Fracture of small Mitroflow(R) aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347.
    PubMed     Abstract available


  325. CONZELMANN LO, Wurth A, Balthasar V, Neuber C, et al
    Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28339.
    PubMed     Abstract available


  326. KOYAMA Y, Yamamoto M, Kagase A, Tsujimoto S, et al
    Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28332.
    PubMed     Abstract available


  327. UESHIMA D, Barioli A, Nai Fovino L, D'Amico G, et al
    The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 May 17. doi: 10.1002/ccd.28335.
    PubMed     Abstract available


  328. OJEDA S, Hidalgo F, Romero M, Mazuelos F, et al
    Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2019 May 7. doi: 10.1002/ccd.28327.
    PubMed     Abstract available


  329. IBRAHIM H, Vapheas E, Shah B, AlKhalil A, et al
    Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28320.
    PubMed     Abstract available


  330. ASHLEY KE, Hillegass WB
    Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
    Catheter Cardiovasc Interv. 2019;93:1137.
    PubMed     Abstract available


    April 2019
  331. ATTINGER-TOLLER A, Htun NM, Murdoch D, Perlman GY, et al
    Transcatheter aortic valve-in-valve implantation for failed surgical bioprosthetic valves. A minimalist approach without contrast aortography or echocardiographic guidance.
    Catheter Cardiovasc Interv. 2019 Apr 30. doi: 10.1002/ccd.28299.
    PubMed     Abstract available


  332. JUNQUERA L, Freitas-Ferraz AB, Padron R, Silva I, et al
    Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323.
    PubMed     Abstract available


  333. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  334. MOHANANEY D, Villablanca P, Gupta T, Ranka S, et al
    Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310.
    PubMed     Abstract available


  335. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Mendez-Bailon M, et al
    Impact of COPD on outcomes in hospitalized patients treated with transcatheter aortic valve implantation or surgical aortic valve replacement in Spain.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28321.
    PubMed     Abstract available


  336. ZHOU D, Pan W, Wang J, Wu Y, et al
    VitaFlow transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28226.
    PubMed     Abstract available


  337. NISHIMURA RA, O'Gara PT, Bavaria JE, Brindis RG, et al
    2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: A proposal to optimize care for patients with valvular heart disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Socie
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28196.
    PubMed    


  338. BERI N, Singh GD, Smith TW, Fan D, et al
    Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes.
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28294.
    PubMed     Abstract available


  339. YOSHIJIMA N, Yanagisawa R, Hase H, Tanaka M, et al
    Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2019 Apr 11. doi: 10.1002/ccd.28279.
    PubMed     Abstract available


  340. RAJ L, Mehra A, Shavelle DM
    Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.
    Catheter Cardiovasc Interv. 2019 Apr 10. doi: 10.1002/ccd.28221.
    PubMed     Abstract available


  341. LANE CE, Eleid MF, Holmes DR Jr
    An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Catheter Cardiovasc Interv. 2019 Apr 5. doi: 10.1002/ccd.28220.
    PubMed     Abstract available


  342. MARMAGKIOLIS K, Hakeem A, Ebersole DG, Iliescu C, et al
    Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2019 Apr 1. doi: 10.1002/ccd.28203.
    PubMed     Abstract available


  343. SAFI LM, Turi ZG
    A match not made in heaven-TAVR prosthesis-patient mismatch with contemporary valves.
    Catheter Cardiovasc Interv. 2019;93:980-981.
    PubMed     Abstract available


    March 2019
  344. AKTUERK D, Jansz P, Shaw M, Muller DWM, et al
    Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28210.
    PubMed     Abstract available


  345. SAIA F, Palmerini T, Compagnone M, Battistini P, et al
    Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28211.
    PubMed     Abstract available


  346. ABAWI M, van Gils L, Agostoni P, van Mieghem NM, et al
    Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175.
    PubMed     Abstract available


  347. BUTTER C, Okamoto M, Schymik G, Jacobshagen C, et al
    Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
    Catheter Cardiovasc Interv. 2019 Mar 13. doi: 10.1002/ccd.28164.
    PubMed     Abstract available


  348. BELARDI JA, Lamelas PM
    Transcatheter aortic valve replacement hemodynamic durability: Still in question?
    Catheter Cardiovasc Interv. 2019;93:739.
    PubMed     Abstract available


  349. KUMAR V, Seth A
    Transcatheter aortic valve replacement: Protect the kidneys to protect the patient.
    Catheter Cardiovasc Interv. 2019;93:749-750.
    PubMed     Abstract available


  350. SHATILA W, Krajcer Z
    TAVI: How to best predict postprocedural outcomes?
    Catheter Cardiovasc Interv. 2019;93:E261.
    PubMed     Abstract available


  351. GILCHRIST IC
    Treating hemolysis due to perivalvular leaks: It is all about modifying micro-jets and not the volume of regurgitation.
    Catheter Cardiovasc Interv. 2019;93:720-721.
    PubMed     Abstract available


    February 2019
  352. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Abstract available


  353. AL-OGAILI A, Fugar S, Okoh A, Kolkailah AA, et al
    Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28156.
    PubMed     Abstract available


  354. LLOYD JW, Joseph TA, Cabalka AK, Guerrero M, et al
    Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28149.
    PubMed     Abstract available


  355. ABBAS AE, Pibarot P
    Hemodynamic characterization of aortic stenosis states.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28146.
    PubMed     Abstract available


  356. JAMES TM, Stamou SC, Rothenberg M, Nores MA, et al
    Transcatheter aortic valve in valve implantation with bioprosthetic valve fracture.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28113.
    PubMed     Abstract available


  357. D'ANCONA G, Ince H, Schillinger W, Senges J, et al
    Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry).
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28127.
    PubMed     Abstract available


  358. KIM J, Alakbarli J, Palumbo MC, Xie LX, et al
    Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two- and three-dimensional echocardiography.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28147.
    PubMed     Abstract available


  359. BLACKMAN DJ, Van Gils L, Bleiziffer S, Gerckens U, et al
    Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28120.
    PubMed     Abstract available


  360. TAKAYUKI G, Volker H, Axel H, Dirk F, et al
    Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28129.
    PubMed     Abstract available


  361. PAREKH DR, Krajcer Z
    Percutaneous pulmonary valve implantation: It's not like the aortic valve.
    Catheter Cardiovasc Interv. 2019;93:464-465.
    PubMed     Abstract available


  362. CHEN B, Dean LS
    HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?
    Catheter Cardiovasc Interv. 2019;93:E202-E203.
    PubMed     Abstract available


  363. KHAN A, Dangas G
    Positioning of self-expanding transcatheter valve prostheses.
    Catheter Cardiovasc Interv. 2019;93:530-531.
    PubMed     Abstract available


  364. SINHA S, Aboulhosn J, Asnes J, Bocks M, et al
    Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:455-463.
    PubMed     Abstract available


  365. JOLLEY MA, Lasso A, Nam HH, Dinh PV, et al
    Toward predictive modeling of catheter-based pulmonary valve replacement into native right ventricular outflow tracts.
    Catheter Cardiovasc Interv. 2019;93:E143-E152.
    PubMed     Abstract available


  366. HO AB, Kaarne M, Mullen M, Hayes N, et al
    Hybrid transcatheter tricuspid valve-in-valve placement of an Edwards Sapien XT valve in palliated hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2019;93:481-483.
    PubMed     Abstract available


  367. MORRAY BH, Jones TK, Coe JY, Gitter R, et al
    Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
    Catheter Cardiovasc Interv. 2019;93:474-480.
    PubMed     Abstract available


  368. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Modified delivery of SAPIEN 3 valve in the pulmonary position: Evolution of technique or dire need?
    Catheter Cardiovasc Interv. 2019;93:484-487.
    PubMed     Abstract available


  369. HACHINOHE D, Latib A, Laricchia A, Demir OM, et al
    Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation.
    Catheter Cardiovasc Interv. 2019;93:522-529.
    PubMed     Abstract available


  370. AL-HIJJI MA, El Sabbagh A, Guerrero ME, Rihal CS, et al
    Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: Early experience and lessons learned.
    Catheter Cardiovasc Interv. 2019 Feb 9. doi: 10.1002/ccd.28131.
    PubMed     Abstract available


  371. BELARDI J, Lamelas P
    TAVR for aortic valve regurgitation: Ready for a randomized trial?
    Catheter Cardiovasc Interv. 2019;93:354-355.
    PubMed     Abstract available


  372. MORGAN GJ, Sadeghi S, Salem MM, Wilson N, et al
    SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:324-329.
    PubMed     Abstract available


    January 2019
  373. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  374. BUTERA G, Hansen JH, Jones MI
    Tricuspid regurgitation complicating SAPIEN 3 valve implantation in pulmonary position.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28083.
    PubMed    


  375. RATTANAWONG P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, et al
    Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28102.
    PubMed     Abstract available


  376. FLINT K, Brieke A, Wiktor D, Carroll J, et al
    Percutaneous edge-to-edge mitral valve repair may rescue select patients in cardiogenic shock: Findings from a single center case series.
    Catheter Cardiovasc Interv. 2019 Jan 24. doi: 10.1002/ccd.28089.
    PubMed     Abstract available


  377. OKOH AK, Haik N, Singh S, Kaur K, et al
    Discharge disposition of older patients undergoing trans-catheter aortic valve replacement and its impact on survival.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28069.
    PubMed     Abstract available


  378. ALDERWEIRELDT AS, De Wolf D
    Percutaneous closure of paravalvular leak after Cone repair for Ebstein's anomaly.
    Catheter Cardiovasc Interv. 2019;93:E46-E48.
    PubMed     Abstract available


    December 2018
  379. CHEN L, Mantri N, Eng ML, Wung W, et al
    Intraprocedural direct left atrial and wedge pressure correlation during transcatheter mitral valve repair: Results from a single center registry.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28035.
    PubMed     Abstract available


  380. CHOI CH, Cheng V, Malaver D, Kon N, et al
    A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28039.
    PubMed     Abstract available


  381. ELGENDY IY, Mahmoud AN, Elbadwai A, Elgendy AY, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Catheter Cardiovasc Interv. 2018 Dec 19. doi: 10.1002/ccd.28050.
    PubMed     Abstract available


  382. POTTER BJ, Thompson C, Green P, Clancy S, et al
    Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28014.
    PubMed     Abstract available


  383. SCHECHTER M, Balanescu DV, Donisan T, Dayah TJ, et al
    An update on the management and outcomes of cancer patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28052.
    PubMed     Abstract available


  384. FINKELSTEIN A, Rozenbaum Z, Zhitomirsky S, Halkin A, et al
    Safety outcomes of new versus old generation transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28021.
    PubMed     Abstract available


  385. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  386. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


  387. AHMED A, Akintoye E, Adegbala O, Yassin A, et al
    In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2018 Dec 2. doi: 10.1002/ccd.27997.
    PubMed     Abstract available


  388. KHAN A, Dangas G
    Transcatheter valve-in-valve for failing bioprosthetic aortic valve: Usually a good idea.
    Catheter Cardiovasc Interv. 2018;92:1412-1413.
    PubMed     Abstract available


    November 2018
  389. YOUNIS A, Orvin K, Nof E, Barabash IM, et al
    The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.28017.
    PubMed     Abstract available


  390. TAKAGI H, Hari Y, Kawai N, Ando T, et al
    Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27948.
    PubMed     Abstract available


  391. JACOBZON E, Wolak A, Fink D, Silberman S, et al
    Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27994.
    PubMed     Abstract available


  392. ABDELGHANI M, Allali A, Kaur J, Hemetsberger R, et al
    Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27977.
    PubMed     Abstract available


  393. BROUWER J, Gheorghe L, Nijenhuis VJ, Ten Berg JM, et al
    Insight on patient specific computer modeling of transcatheter aortic valve implantation in patients with bicuspid aortic valve disease.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27990.
    PubMed     Abstract available


  394. JOSEPH TA, Eleid MF, Cabalka AK, Maalouf JF, et al
    Long-term outcomes of melody valve-in-valve implantation for bioprosthetic mitral valve dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27988.
    PubMed     Abstract available


  395. LEHNER A, Herrmann FE, Mehilli J, Haas NA, et al
    Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27975.
    PubMed     Abstract available


  396. MODOLO R, Miyazaki Y, Chang CC, Te Lintel Hekkert M, et al
    Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27972.
    PubMed     Abstract available


  397. CHENG R, Kar S, Siegel RJ, Nakamura M, et al
    Cleft mitral leaflets and severe mitral regurgitation: Testing the limits of percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27980.
    PubMed     Abstract available


  398. PAN W, Pan C, Jilaihawi H, Wei L, et al
    A novel user-friendly transcatheter edge-to-edge mitral valve repair device in a porcine model.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27976.
    PubMed     Abstract available


  399. BUTTER C, Kaneko H, Tambor G, Hara M, et al
    Clinical utility of intraprocedural three-dimensional integrated image guided transcatheter aortic valve implantation using novel automated computed tomography software: A single-center preliminary experience.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27920.
    PubMed     Abstract available


  400. SPINA R, Khalique O, Kodali S, Bapat VN, et al
    Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27954.
    PubMed     Abstract available


  401. ANDO T, Adegbala O, Villablanca PA, Briasoulis A, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in non-teaching hospitals.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27968.
    PubMed     Abstract available


  402. DOWLING C, Firoozi S, Doyle N, Blackman DJ, et al
    Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2018 Nov 5. doi: 10.1002/ccd.27934.
    PubMed     Abstract available


  403. KUMAR A, Block PC
    Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!
    Catheter Cardiovasc Interv. 2018;92:981-982.
    PubMed     Abstract available


    October 2018
  404. MORRICAL BD, Dearani JA, Cabalka AK
    Melody valve in mitral position: Complete fracture causing acute mitral stenosis in a child.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27683.
    PubMed     Abstract available


  405. BEN-DOR I, Rogers T, Satler LF, Waksman R, et al
    A word of caution using self-expanding transcatheter aortic valve-frame infolding.
    Catheter Cardiovasc Interv. 2018 Oct 30. doi: 10.1002/ccd.27870.
    PubMed     Abstract available


  406. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  407. PINEDA AM, Kevin Harrison J, Kleiman NS, Reardon MJ, et al
    Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 20. doi: 10.1002/ccd.27928.
    PubMed     Abstract available


  408. SPIEKER M, Hellhammer K, Wiora J, Klose S, et al
    Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Oct 17. doi: 10.1002/ccd.27906.
    PubMed     Abstract available


  409. KUMAR A, Sato K, Banerjee K, Narayanswami J, et al
    Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27927.
    PubMed     Abstract available


  410. LI J, Patel SM, Nadeem F, Thakker P, et al
    Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27894.
    PubMed     Abstract available


  411. MISUMIDA N, Pagath M, Ogunbayo GO, Wilson RE, et al
    Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27915.
    PubMed     Abstract available


  412. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Long-term clinical outcome of persistent left bundle branch block after transfemoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27850.
    PubMed     Abstract available


  413. NELSON BC, Chadderdon S, Song H, Zahr FE, et al
    Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27721.
    PubMed     Abstract available


  414. BUCHANAN KD, Rogers T, Steinvil A, Koifman E, et al
    Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27914.
    PubMed     Abstract available


    September 2018
  415. RAWASIA WF, Khan MS, Usman MS, Siddiqi TJ, et al
    Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27840.
    PubMed     Abstract available


  416. MAS-PEIRO S, Weiler H, Papadopoulos N, Zeiher AM, et al
    Post/preprocedural ratio of hemodynamically assessed aortic regurgitation index as a marker for the need for corrective measures during transcatheter valve replacement: A first confirmatory study in patients receiving a new generation transcatheter se
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27847.
    PubMed     Abstract available


  417. MORI M, Bin Mahmood SU, Geirsson A, Yun JJ, et al
    Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27855.
    PubMed     Abstract available


  418. EDRIS A, Bartel T, Tuzcu EM, Suri RM, et al
    Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27723.
    PubMed     Abstract available


  419. DENEGRI A, Mehran R, Holy E, Taramasso M, et al
    Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome
    Catheter Cardiovasc Interv. 2018 Sep 30:e27806. doi: 10.1002/ccd.27806.
    PubMed     Abstract available


  420. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Abstract available


  421. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Abstract available


  422. MADUKAUWA-DAVID ID, Midha PA, Sharma R, McLain K, et al
    Characterization of aortic root geometry in transcatheter aortic valve replacement patients.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27805.
    PubMed     Abstract available


  423. BAVARIA JE, Tommaso CL, Brindis RG, Carroll JD, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811.
    PubMed    


  424. HERNANDEZ-ENRIQUEZ M, Regueiro A, Romaguera R, Andrea R, et al
    Thrombocytopenia after transcatheter aortic valve implantation. A comparison between balloon-expandable and self-expanding valves.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27907.
    PubMed     Abstract available


  425. RAPHAEL CE, Malouf JF, Maor E, Panaich SS, et al
    A hybrid technique for treatment of commissural primary mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27904.
    PubMed     Abstract available


  426. GARCIA S, Mbai M, Kelly R, Bertog S, et al
    Simultaneous transfemoral transcatheter aortic valve replacement and trans-septal mitral valve-in-ring implantation after partial laceration of an Alfieri stitch.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27875.
    PubMed     Abstract available


  427. PIAYDA K, Hellhammer K, Veulemans V, Zeus T, et al
    Valvuloplasty balloon entrapment in a self-expanding aortic valve stent frame after inadvertent wire passage through the outflow struts.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27858.
    PubMed     Abstract available


  428. ATHAYDE GRS, Nascimento BR, Elmariah S, Lodi-Junqueira L, et al
    Impact of left atrial compliance improvement on functional status after percutaneous mitral valvuloplasty.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27831.
    PubMed     Abstract available


  429. LAZKANI M, Sawant AC, Taase A, Khan S, et al
    Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27804. doi: 10.1002/ccd.27804.
    PubMed     Abstract available


  430. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Abstract available


  431. RASHID HN, Nasis A, Gooley RP, Cameron JD, et al
    The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27702.
    PubMed     Abstract available


  432. VAN MOURIK MS, Janmaat YC, van Kesteren F, Vendrik J, et al
    CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27823.
    PubMed     Abstract available


  433. BRAUN D, Nabauer M, Massberg S, Hausleiter J, et al
    One-stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27848.
    PubMed     Abstract available


  434. GORLA R, Cannone GS, Bedogni F, De Marco F, et al
    Transfemoral aortic valve implantation following lithoplasty of iliac artery in a patient with poor vascular access.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27812.
    PubMed     Abstract available


    August 2018
  435. ATTISANO T, Silverio A, Stabile E, Briguori C, et al
    Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The "BAV for life" experience.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27820.
    PubMed     Abstract available


  436. AZIZ M, Simonato M, Webb JG, Abdel-Wahab M, et al
    Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID).
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27714.
    PubMed     Abstract available


  437. LLOYD JW, Reeder GS, Rihal CS, Eleid MF, et al
    Effect of saline administration on left atrial pressure during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27710.
    PubMed     Abstract available


  438. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed    


  439. LEMOS PA, Makdisse M
    The less complex the case is, the more complex is it to choose? The case of lower risk patients with aortic valve stenosis.
    Catheter Cardiovasc Interv. 2018;92:399-400.
    PubMed    


  440. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed    


    July 2018
  441. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Abstract available


  442. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Abstract available


  443. MAKKI N, Ghao X, Whitson B, Shreenivas S, et al
    Slope of left ventricular filling as an index of valvular and paravalvular regurgitation in native and prosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27684.
    PubMed     Abstract available


  444. UESHIMA D, Nai Fovino L, Mojoli M, Napodano M, et al
    The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27681.
    PubMed     Abstract available


  445. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Abstract available


    June 2018
  446. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Abstract available


    May 2018
  447. HACHINOHE D, Latib A, Montorfano M, Colombo A, et al
    Transcatheter mitral valve implantation in rigid mitral annuloplasty rings: Potential differences between complete and incomplete rings.
    Catheter Cardiovasc Interv. 2018 May 18. doi: 10.1002/ccd.27658.
    PubMed     Abstract available


  448. ASMARATS L, Rodriguez-Gabella T, Chamandi C, Bernier M, et al
    Infective endocarditis following transcatheter edge-to-edge mitral valve repair: A systematic review.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27632.
    PubMed     Abstract available


    April 2018
  449. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed    


  450. SAJI M, Katz MR, Ailawadi G, Welch TS, et al
    6-Minute walk test predicts prolonged hospitalization in patients undergoing transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2018 Apr 15. doi: 10.1002/ccd.27600.
    PubMed     Abstract available


  451. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Abstract available


  452. KRISHNAN SK, Dean LS
    Looking for the bare necessities.
    Catheter Cardiovasc Interv. 2018;91:956-957.
    PubMed     Abstract available


  453. BURZOTTA F, Trani C
    TAVR technique tries to go higher than bicuspid valve hurdles.
    Catheter Cardiovasc Interv. 2018;91:995-996.
    PubMed     Abstract available


    March 2018
  454. YE J, Lee AJ, Blanke P, Webb J, et al
    The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
    PubMed     Abstract available


  455. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Abstract available


  456. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Abstract available


  457. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Abstract available


  458. TAKAHASHI M, Badenco N, Monteau J, Gandjbakhch E, et al
    Impact of pacemaker mode in patients with atrioventricular conduction disturbance after trans-catheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Mar 14. doi: 10.1002/ccd.27594.
    PubMed     Abstract available


  459. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Abstract available


  460. ABDELGHANI M, de Winter RJ, Miyazaki Y, Modolo R, et al
    Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27538.
    PubMed     Abstract available


  461. MALCOLMSON JW, Hamshere SM, Joshi A, O'Mahony C, et al
    Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2018;91:783-789.
    PubMed     Abstract available


  462. MIZOTE I, Schirmer J, Schafer U
    A case of successful Mitraclip implantation in a patient having a large coaptation gap under extracorporeal membrane oxygenation (ECMO).
    Catheter Cardiovasc Interv. 2018;91:827-830.
    PubMed     Abstract available


    February 2018
  463. SARAF S, Cockburn J, Alsanjari O, Hildick-Smith D, et al
    Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27544.
    PubMed     Abstract available


  464. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Abstract available


  465. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Abstract available


  466. BENSON L
    PPVI in children under 20 kilograms: A quid pro quo?
    Catheter Cardiovasc Interv. 2018;91:495-496.
    PubMed     Abstract available


  467. KHAN JM, Rogers T, Schenke WH, Greenbaum AB, et al
    Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27531.
    PubMed     Abstract available


  468. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Abstract available


  469. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Abstract available


  470. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Abstract available


  471. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Abstract available


  472. DI MARIO C, Sorini Dini C
    Maximal efficiency is required to minimize complications and hospital stay after TAVR.
    Catheter Cardiovasc Interv. 2018;91:354-355.
    PubMed     Abstract available


  473. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Abstract available


    January 2018
  474. SCHAFER U, Kalbacher D, Voigtlander L, Conradi L, et al
    First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27466.
    PubMed     Abstract available


  475. TSURUTA H, Hayashida K, Yashima F, Yanagisawa R, et al
    Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27508.
    PubMed     Abstract available


  476. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Abstract available


  477. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Abstract available


  478. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Abstract available


  479. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Abstract available


  480. AMAT-SANTOS IJ, Rojas P, Gutierrez H, Vera S, et al
    Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27485.
    PubMed     Abstract available


  481. ROGERS T, Lederman RJ
    Percutaneous transaxillary access for TAVR: Another opportunity to stay out of the chest.
    Catheter Cardiovasc Interv. 2018;91:157-158.
    PubMed     Abstract available


  482. AUBERSON D, Gray W
    Good enough...isn't.
    Catheter Cardiovasc Interv. 2018;91:148-149.
    PubMed     Abstract available


  483. GOLESKI PJ, Reisman M, Don CW
    Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018;91:165-168.
    PubMed     Abstract available


  484. NERLA R, Cremonesi A, Castriota F
    Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018;91:169-174.
    PubMed     Abstract available


    December 2017
  485. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Abstract available


  486. HACHINOHE D, Latib A, Agricola E, Colombo A, et al
    Repeat MitraClip for early recurrent mitral regurgitation.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27460.
    PubMed     Abstract available


  487. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Abstract available


  488. PATEL JS, Krishnaswamy A, White J, Mick S, et al
    Optimizing hemodynamics of transcatheter aortic valve-in-valve implantation in 19-mm surgical aortic prostheses.
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27415.
    PubMed     Abstract available


  489. NAKAJIMA Y, Kar S
    First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.
    Catheter Cardiovasc Interv. 2017 Dec 8. doi: 10.1002/ccd.27438.
    PubMed     Abstract available


  490. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Abstract available


  491. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Abstract available


  492. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Abstract available


    November 2017
  493. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Abstract available


  494. ELEID MF, Reeder GS, Rihal CS
    Comparison of left atrial pressure monitoring with dedicated catheter versus steerable guiding catheter during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27430.
    PubMed     Abstract available


  495. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Abstract available


  496. TRENKWALDER T, Pellegrini C, Holzamer A, Philipp A, et al
    Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385.
    PubMed     Abstract available


  497. MAYR NP, Wiesner G, Hapfelmeier A, van der Starre P, et al
    Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27382.
    PubMed     Abstract available


  498. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Abstract available


  499. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Abstract available


  500. ALMEIDA JG, Ferreira SM, Fonseca P, Dias T, et al
    Comparison of self-expanding and balloon-expandable transcatheter aortic valves morphology and association with paravalvular regurgitation: Evaluation using multidetector computed tomography.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27401.
    PubMed     Abstract available


    October 2017
  501. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Abstract available


  502. FLUECKIGER P, Singleton M, Vasu S, Zhao D, et al
    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27217.
    PubMed     Abstract available


  503. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Abstract available


  504. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Abstract available


  505. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Abstract available


  506. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Abstract available


  507. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Abstract available


  508. RUPARELIA N, Cao J, Newton JD, Wilson N, et al
    Paravalvular leak closure under intracardiac echocardiographic guidance.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27318.
    PubMed     Abstract available


  509. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Abstract available


  510. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Abstract available


  511. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Abstract available


  512. DALL'ARA G, Santarelli A, Marzocchi A, Bacchi Reggiani ML, et al
    Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27328.
    PubMed     Abstract available


  513. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Abstract available


    September 2017
  514. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Abstract available


  515. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Abstract available


  516. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Abstract available


  517. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Abstract available


  518. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Abstract available


  519. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Abstract available


  520. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Abstract available


  521. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Abstract available


    August 2017
  522. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Abstract available


  523. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Abstract available


  524. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Abstract available


  525. KRISHNAN S, Daniels D, McCabe JM
    Novel bipolar preshaped left ventricular pacing wire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 11. doi: 10.1002/ccd.27244.
    PubMed    


  526. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Abstract available


  527. TELILA T, Akintoye E, Ando T, Merid O, et al
    Hospital teaching status and trascatheter aortic valve replacement outcomes in the United States: Analysis of the national inpatient sample.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27236.
    PubMed     Abstract available


  528. WATERBURY TM, Reeder GS, Pislaru SV, Cabalka AK, et al
    Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27224.
    PubMed     Abstract available


  529. KHAN JM, Lederman RJ
    Unnatural milieu: Thrombus after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2017;90:329-330.
    PubMed     Abstract available


  530. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Abstract available


    July 2017
  531. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Abstract available


  532. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Abstract available


    June 2017
  533. KOEHLE M, Strote JA, Guadagnoli M, Oldemeyer JB, et al
    A novel mechanical mitral valve replacement using Sapien XT.
    Catheter Cardiovasc Interv. 2017 Jun 9. doi: 10.1002/ccd.27149.
    PubMed     Abstract available


  534. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Abstract available


  535. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Abstract available


  536. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Abstract available


  537. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Abstract available


    May 2017
  538. GUERRERO M, Salinger M, Pursnani A, Pearson P, et al
    Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care.
    Catheter Cardiovasc Interv. 2017 May 30. doi: 10.1002/ccd.27128.
    PubMed     Abstract available


  539. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Abstract available


  540. HO EC, Ahmed N, Connelly KA, Fam NP, et al
    Transcatheter edge-to-edge repair of anterior mitral flail through a dehisced annuloplasty ring.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27126.
    PubMed     Abstract available


  541. WITBERG G, Finkelstein A, Barbash I, Assali A, et al
    Prognostic significance of aortic valve gradient in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27124.
    PubMed     Abstract available


  542. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Abstract available


  543. LINKE A, Chandrasekhar J, Sartori S, Lefevre T, et al
    Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27154.
    PubMed     Abstract available


  544. HENGSTENBERG C, Chandrasekhar J, Sartori S, Lefevre T, et al
    Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 11. doi: 10.1002/ccd.27155.
    PubMed     Abstract available


  545. GEORGE B, Voelkel A, Kotter J, Leventhal A, et al
    A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno-venous bypass: A single center experience.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27097.
    PubMed     Abstract available


  546. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Abstract available


  547. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Abstract available


  548. GREENBAUM AB, Condado JF, Eng M, Lerakis S, et al
    Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27054.
    PubMed     Abstract available


  549. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Abstract available


  550. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Abstract available


  551. ALRAIES MC, Satler LF
    End-stage renal disease and severe aortic stenosis. Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017;89:1116-1117.
    PubMed    


    April 2017
  552. HERRMANN HC, Szeto WY, Litt H, Vernick W, et al
    Novel use of perfusion balloon inflation to avoid outflow tract obstruction during transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27068.
    PubMed     Abstract available


  553. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Abstract available


  554. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Abstract available


  555. RUIZ CE, Chi-Hion L, Vladimir J, Gila P, et al
    Hopscotch technique: A novel method for percutaneous closure of paravalvular leaks.
    Catheter Cardiovasc Interv. 2017;89:944-950.
    PubMed     Abstract available


    March 2017
  556. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Abstract available


  557. TANG GH, Cohen M, Dutta T, Undemir C, et al
    Afterload mismatch after transcatheter mitral valve repair with MitraClip for degenerative mitral regurgitation in acute cardiogenic shock.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27019.
    PubMed     Abstract available


  558. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Abstract available


  559. KHERADA N, Brenes JC, Kini AS, Dangas GD, et al
    Assessment of trans-aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26962.
    PubMed     Abstract available


  560. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Abstract available


  561. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Abstract available


  562. SUMMERS MR, Mick S, Kapadia SR, Krishnaswamy A, et al
    Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26990.
    PubMed     Abstract available


  563. AL'AREF SJ, Devereux RB, Cheung JW, Bergman G, et al
    Bioprosthetic mitral valve paravalvular leak closure using intracardiac echocardiography-guided three dimensional electroanatomic mapping.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26958.
    PubMed     Abstract available


  564. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Abstract available


  565. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Abstract available


  566. GUERRERO M, Wang DD, Himbert D, Urena M, et al
    Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26975.
    PubMed     Abstract available


  567. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Abstract available


  568. LIAO YB, Zhao ZG, Wei X, Xu YN, et al
    Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Abstract available


  569. CAIXETA A, Lemos PA
    Transcatheter aortic valve replacement by a minimalist approach: A breath of fresh air for patients with chronic obstructive pulmonary disease.
    Catheter Cardiovasc Interv. 2017;89:781-782.
    PubMed    


  570. HEIN-ROTHWEILER R, Jochheim D, Rizas K, Egger A, et al
    Aortic annulus to left coronary distance as a predictor for persistent left bundle branch block after TAVI.
    Catheter Cardiovasc Interv. 2017;89:E162-E168.
    PubMed     Abstract available


  571. STEINVIL A, Satler L
    Does the removal of the temporary pacer wire for BAV and TAVR really simplify the procedure?
    Catheter Cardiovasc Interv. 2017;89:787-788.
    PubMed    


    February 2017
  572. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Abstract available


  573. JAMES RODRIGUEZ R, Prasad A
    Transcatheter aortic valve replacement and renal function: A complex relationship.
    Catheter Cardiovasc Interv. 2017;89:460-461.
    PubMed    


  574. CONDADO JF, Block PC
    Gender inequalities in transcatheter aortic valve replacement: The jury is still out.
    Catheter Cardiovasc Interv. 2017;89:436-437.
    PubMed    


  575. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Abstract available


  576. PELBERG J, Gray WA
    Good to great: TAVR tackles stroke risk.
    Catheter Cardiovasc Interv. 2017;89:478-479.
    PubMed    


  577. YADAV PK, Gilchrist IC
    Significant leak after TAVR: A plug is an option.
    Catheter Cardiovasc Interv. 2017;89:468-469.
    PubMed    


  578. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Abstract available


  579. SORAJJA P, Kanda B, Bae R, Pedersen WA, et al
    Maneuvers for technical success with transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26899.
    PubMed     Abstract available


  580. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Abstract available


  581. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Abstract available


  582. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Abstract available


  583. HAGLER DJ
    The Lababidi Procedure: Is Neonatal Balloon Aortic Valvotomy Worth the Risk?
    Catheter Cardiovasc Interv. 2017;89:296-297.
    PubMed    


    January 2017
  584. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Abstract available


  585. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Abstract available


  586. MCCABE JM, Dean LS
    Pass the Rock: calcium, the achilles heel of transcatheter valve replacement.
    Catheter Cardiovasc Interv. 2017;89:142-143.
    PubMed     Abstract available


    December 2016
  587. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Abstract available


  588. RASMUSSEN VG, Kanstrup HL, Nielsen-Kudsk JE
    Percutaneous balloon valvuloplasty in carcinoid pulmonary valve stenosis.
    Catheter Cardiovasc Interv. 2016;88:1174-1176.
    PubMed     Abstract available


  589. MILLAN X, Azzalini L, Khan R, Cournoyer D, et al
    Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients.
    Catheter Cardiovasc Interv. 2016;88:1145-1152.
    PubMed     Abstract available


  590. CILINGIROGLU M, Marmagkiolis K
    Invasive Hemodynamic Assessment During Mitra-Clip Implantation: Should It Be the New Standard?
    Catheter Cardiovasc Interv. 2016;88:1143-1144.
    PubMed     Abstract available


    November 2016
  591. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Abstract available


  592. MASSUMI M, Krajcer Z
    To BAV or not to BAV, that is a TAVR question.
    Catheter Cardiovasc Interv. 2016;88:986-987.
    PubMed    


  593. YADAV PK, Eng MH
    A toast to no sternotomy.
    Catheter Cardiovasc Interv. 2016;88:960-961.
    PubMed    


  594. GUERRERO I, Dhoble A, Fasulo M, Denktas AE, et al
    Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:971-977.
    PubMed     Abstract available


  595. FAURIE B, Abdellaoui M, Wautot F, Staat P, et al
    Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.
    Catheter Cardiovasc Interv. 2016;88:988-993.
    PubMed     Abstract available


  596. RUPARELIA N, Mangieri A, Ancona M, Giannini F, et al
    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.
    Catheter Cardiovasc Interv. 2016;88:994-1001.
    PubMed     Abstract available


  597. FORTUNATO DE CANO S, Nicolas Cano M, de Ribamar Costa J Jr, Alves Pinheiro J Jr, et al
    Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:953-960.
    PubMed     Abstract available


  598. CORRIGAN FE 3RD, Douglas JS Jr
    Now you see me, now you don't: The case of a vanishing outflow gradient in a patient with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:1006-1009.
    PubMed     Abstract available


  599. PRASAD M, Geske JB, Sorajja P, Ommen SR, et al
    Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Catheter Cardiovasc Interv. 2016;88:962-970.
    PubMed     Abstract available


  600. LIEBREGTS M, Vriesendorp PA, Steggerda RC, Schinkel AF, et al
    Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:945-952.
    PubMed     Abstract available


  601. KAWASE Y, Matsuo H
    A modified method (MK method) of alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopahty.
    Catheter Cardiovasc Interv. 2016;88:1002-1005.
    PubMed     Abstract available


  602. CONDADO JF, Haider MN, Lerakis S, Keegan P, et al
    Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26683.
    PubMed     Abstract available


  603. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Abstract available


  604. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Abstract available


  605. PICARD F, Tadros VX, Asgar AW
    From tricuspid to double orifice Morphology: Percutaneous tricuspid regurgitation repair with the MitraClip device in congenitally corrected-transposition of great arteries.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26834.
    PubMed     Abstract available


  606. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed    


  607. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Abstract available


  608. LINDSAY I, Aboulhosn J, Salem M, Levi D, et al
    Aortic root compression during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:814-821.
    PubMed     Abstract available


  609. PATIL NC, Saxena A, Gupta SK, Juneja R, et al
    Perforating the atretic pulmonary valve with CTO hardware: Technical aspects.
    Catheter Cardiovasc Interv. 2016;88:E145-E150.
    PubMed     Abstract available


  610. CHAKRABORTY S, Vadivelu R, Bagga S
    Percutaneous balloon mitral valvuloplasty under neuroprotection: Too Early for Knighthood.
    Catheter Cardiovasc Interv. 2016;88:E151-E154.
    PubMed     Abstract available


    October 2016
  611. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Abstract available


  612. KISCHE S, D'Ancona G, Agma HU, El-Achkar G, et al
    Trans-catheter aortic valve implantation with the direct flow medical prosthesis: Single center short-term clinical and echocardiographic outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26528.
    PubMed     Abstract available


  613. D'ANCONA G, Agma HU, Ince H, El-Achkar G, et al
    Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26517.
    PubMed     Abstract available


  614. HILLING-SMITH R, Cockburn J, Dooley M, Parker J, et al
    Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2016 Oct 11. doi: 10.1002/ccd.26720.
    PubMed     Abstract available


  615. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Abstract available


  616. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Abstract available


  617. SCHNEIDER AE, Delaney JW, Cabalka AK
    Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
    Catheter Cardiovasc Interv. 2016;88:600-604.
    PubMed     Abstract available


  618. YILDIRIM A, Goktekin O, Gorgulu S, Norgaz T, et al
    A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial.
    Catheter Cardiovasc Interv. 2016;88:618-624.
    PubMed     Abstract available


  619. DAVIDSON LJ, Davidson CJ
    Stroke Prevention: Let's Prepare for Generation X TAVR.
    Catheter Cardiovasc Interv. 2016;88:653-655.
    PubMed     Abstract available


    September 2016
  620. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Abstract available


  621. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Abstract available


  622. SULLIVAN PM, Rubio AE, Johnston TA, Jones TK, et al
    Long-term outcomes and re-interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single-center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26722.
    PubMed     Abstract available


  623. HAMM K, Zacher M, Hautmann M, Gietzen F, et al
    Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair-a single center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26806.
    PubMed     Abstract available


  624. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Abstract available



  625. Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Impact of Preprocedural Left Ventricular Diastolic Filling Patterns on Late Clinical Outcomes. DOI: 10.1002/ccd.26298.
    Catheter Cardiovasc Interv. 2016;88:500.
    PubMed    


  626. BROWN SC, Cools B, Gewillig M
    Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.
    Catheter Cardiovasc Interv. 2016;88:456-9.
    PubMed     Abstract available


  627. FELDMAN T, Pearson P, Smart SS
    Percutaneous closure of post TAVR LV apical pseudoaneurysm.
    Catheter Cardiovasc Interv. 2016;88:479-85.
    PubMed     Abstract available


  628. KORNOWSKI R
    The 3 S's of the Sapien balloon expandable valve.
    Catheter Cardiovasc Interv. 2016;88:476-8.
    PubMed     Abstract available


    August 2016
  629. JIVANJI SG, Derrick G, Khambadkone S
    Doubly committed subarterial ventricular septal defect: A risk factor for aortic distortion in patients considered for percutaneous pulmonary valve implantation?
    Catheter Cardiovasc Interv. 2016;88:244-7.
    PubMed     Abstract available


  630. SPITZER SG, Wilbring M, Alexiou K, Stumpf J, et al
    Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Catheter Cardiovasc Interv. 2016;88:E52-8.
    PubMed     Abstract available


  631. CAMMALLERI V, Romeo F, Ussia GP
    Hemodynamic complications during transcatheter MitraClip repair in presence of congenital atrial septal defect.
    Catheter Cardiovasc Interv. 2016;88:307-11.
    PubMed     Abstract available


  632. SAFIAN RD, Hanzel G
    Management of vascular access after TAVR: Let's keep it simple.
    Catheter Cardiovasc Interv. 2016;88:285-6.
    PubMed     Abstract available


    July 2016
  633. ABU SALEH WK, Tang GH, Ahmad H, Cohen M, et al
    Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
    Catheter Cardiovasc Interv. 2016;88:135-43.
    PubMed     Abstract available


  634. SEGUELA PE, Roubertie F, Thambo JB
    Distortion of the left anterior descending coronary artery after pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:99-102.
    PubMed     Abstract available


  635. SINGH K, Qutub M, Carson K, Hibbert B, et al
    A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:107-15.
    PubMed     Abstract available


  636. FRISOLI TM, Guerrero M, O'Neill WW
    Mechanical circulatory support with impella to facilitate percutaneous coronary intervention for post-TAVI bilateral coronary obstruction.
    Catheter Cardiovasc Interv. 2016;88:E34-7.
    PubMed     Abstract available


  637. YADAV PK, Eng MH
    Size does matter but is there an obesity paradox in TAVR?
    Catheter Cardiovasc Interv. 2016;88:125-6.
    PubMed     Abstract available


  638. BADER Y, Kimmelstiel C
    Ablation or surgery for medically refractory HCM. Updating an imperfect dataset.
    Catheter Cardiovasc Interv. 2016;88:116-7.
    PubMed     Abstract available


    June 2016
  639. GILCHRIST IC, Hansen J
    Between a rock and a hard place: TAVR and ESRD.
    Catheter Cardiovasc Interv. 2016;87:1322-3.
    PubMed     Abstract available


    April 2016
  640. INOHARA T, Hayashida K, Watanabe Y, Yamamoto M, et al
    Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.
    Catheter Cardiovasc Interv. 2016;87:963-70.
    PubMed     Abstract available


  641. FUJITA B, Scholtz S, Ensminger S
    Valve-in-valve using an Edwards Sapien XT into a JenaValve in a patient with a low originating left coronary artery and a heavily calcified aorta.
    Catheter Cardiovasc Interv. 2016;87:989-92.
    PubMed     Abstract available


    March 2016
  642. BOE BA, Bocks ML, Armstrong AK
    Contained rupture of patched right ventricular outflow tracts during balloon sizing for percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2016;87:768-72.
    PubMed     Abstract available


  643. ELEID MF, Asirvatham SJ, Cabalka AK, Hagler DJ, et al
    Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads.
    Catheter Cardiovasc Interv. 2016;87:E160-5.
    PubMed     Abstract available


    February 2016
  644. PHILLIPS AB, Nevin P, Shah A, Olshove V, et al
    Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of fallot.
    Catheter Cardiovasc Interv. 2016;87:403-10.
    PubMed     Abstract available


  645. MULLER B, Ghawi H, Heitschmidt MG, Fogg L, et al
    Medium-term CT evaluation of stent geometry, integrity, and valve function of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.
    Catheter Cardiovasc Interv. 2016;87:E97-103.
    PubMed     Abstract available


  646. SMOLKA G, Pysz P, Jasinski M, Roleder T, et al
    Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: A prospective registry.
    Catheter Cardiovasc Interv. 2016;87:478-87.
    PubMed     Abstract available


    January 2016
  647. TOMMASO CL
    Learning curves for TAVR: Not quite see one, do one teach one.
    Catheter Cardiovasc Interv. 2016;87:163-4.
    PubMed     Abstract available


  648. CILINGIROGLU M, Marmagkiolis K
    A glimpse into the future of TAVR.
    Catheter Cardiovasc Interv. 2016;87:152-3.
    PubMed     Abstract available


  649. HOLZER RJ, Hijazi ZM
    Transcatheter pulmonary valve replacement: State of the art.
    Catheter Cardiovasc Interv. 2016;87:117-28.
    PubMed     Abstract available


  650. NOAD RL, Johnston N, McKinley A, Dougherty M, et al
    A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.
    Catheter Cardiovasc Interv. 2016;87:134-42.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: